Background Allergen immunotherapy is the only potentially disease-modifying treatment for IgE-mediated respiratory allergy. Among the available routes, sublingual immunotherapy (SLIT) has gained prominence because of its favorable safety profile and greater patient acceptability. Objectives This narrative review critic...
G. Paoletti, N. Valli, D. di Bona et al.· Frontiers in Allergy· 0 citations
BACKGROUND
Biologics are generally reserved for severe asthma (SA) after standard treatments have failed. Their recommendation is based on randomized controlled trials, designed to assess efficacy but not the optimal timing for biologic initiation.
RESEARCH QUESTION
Does the timing of biologic initiation affect SA ou...
G. Canonica, G. Christoff, Ming-Ju Tsai et al.· Chest· 0 citations
RATIONALE
The efficacy of biologics remains debatable in current or ex- smokers with severe asthma.
OBJECTIVES
This study aimed to evaluate responses to biologics by smoking exposure and to assess variations in management practice across Europe.
METHODS
This was a retrospective real-world study of adults with sever...
M. Caminati, J. Charriot, A. Bansal et al.· American Journal of Respirat...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.